Histamine and increased ovarian blood flow mediate LH-induced superovulation in the cyclic hamster.
Constant infusion of LH (400 micrograms NIH-S24) through an osmotic minipump inserted on Day 1 (oestrus) of the cycle in the hamster resulted in spontaneous superovulation (approximately equal to 29 ova) at the next expected oestrus, increased blood flow (P less than 0.001) to the ovary on Day 3, and slight depletion (0.1 greater than P greater than 0.05) of histamine in the ovary. Treatment with antihistamine (alpha-fluoromethylhistidine, an irreversible inhibitor of histidine decarboxylase, or cimetidine, an H2 blocker) by injections or by infusion using separate osmotic minipumps significantly (P less than 0.01) reduced the number of ova shed in the LH-treated hamsters. Infusion of LH with alpha-fluoromethylhistidine in the same osmotic minipump reduced the bioactivity of the LH. Infusion of antihistamine alone did not alter the normal number of ova shed. The results suggest that the LH-induced superovulation involves stimulation of histamine release; the histamine than may increase ovarian blood flow thus allowing more gonadotrophins to reach the ovary.
D000818:Animals; D006224:Cricetinae; D004971:Estrus; D005260:Female; D006632:Histamine / Q000097:blood* / Q000378:metabolism; D006633:Histamine Antagonists / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000378:metabolism / Q000494:pharmacology*; D008762:Methylhistidines / Q000494:pharmacology; D010053:Ovary / Q000098:blood supply* / Q000378:metabolism; D010060:Ovulation / Q000187:drug effects; D013480:Superovulation / Q000187:drug effects
D006633:Histamine Antagonists; D008762:Methylhistidines; C028309:alpha-fluoromethylhistidine; D006632:Histamine; D007986:Luteinizing Hormone